The nonintoxicating strain of marijuana oil approved last year by lawmakers is still not on the market, with state regulations for the so-called Charlotte’s Web product ensnared by legal challenges. A bill (CS/SB 7066) by Sen. Rob Bradley, R-Orange Park, adds qualifying medical conditions but keeps the proposed products non-euphoric, drawing fresh opposition.

The Florida Cannabis Action Network, a leading advocacy group, opposes the measure. Jodi James, FCAN’s executive director, said Bradley’s rework of last year’s legislation is bound to give “false hope,” to even more patients.

James said a higher level of tetrahydrocannabinol (THC), is needed, with the compound which produces a high the only way to help a broader base of patients added in Bradley’s bill. He proposes making those suffering from Parkinson’s disease, AIDS, HIV and multiple sclerosis among those added to the list of eligible users of the marijuana oil.

“It’s just not going to work for these people without higher THC,” James said.